搜尋





搜尋





市場行情
/
股票
/
crnx
/

Crinetics Pharmaceuticals Inc

CRNX

添加自選

83.750USD

-0.100-0.12%

收盤 07-27 16:00（美東）報價延遲15分鐘

8.82B總市值

虧損本益比TTM

Crinetics Pharmaceuticals Inc

83.750

-0.100-0.12%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

CRNX 利潤表

您可以在這裡找到Crinetics Pharmaceuticals Inc的年度或季度收入報告，以深入了解Crinetics Pharmaceuticals Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

營業總收入

2873.41%10.73M

--6.16M

--143.00K

158.40%1.03M

-43.59%361.00K

--0.00

-100.00%0.00

-59.62%399.00K

-76.11%640.00K

-100.00%0.00

-24.45%346.00K

125.06%988.00K

-14.44%2.68M

-34.23%709.00K

--458.00K

--439.00K

--3.13M

--1.08M

--0.00

-100.00%0.00

--0.00

-80.65%71.00K

-58.90%321.00K

-7.85%505.00K

-100.00%0.00

-16.97%367.00K

47.92%781.00K

-14.37%548.00K

-21.03%657.00K

882.22%442.00K

--528.00K

--640.00K

--832.00K

--45.00K

營業收入

2873.41%10.73M

--6.16M

--143.00K

158.40%1.03M

-43.59%361.00K

--0.00

-100.00%0.00

-59.62%399.00K

-76.11%640.00K

-100.00%0.00

-24.45%346.00K

125.06%988.00K

-14.44%2.68M

-34.23%709.00K

--458.00K

--439.00K

--3.13M

--1.08M

--0.00

-100.00%0.00

--0.00

-80.65%71.00K

-58.90%321.00K

-7.85%505.00K

-100.00%0.00

-16.97%367.00K

47.92%781.00K

-14.37%548.00K

-21.03%657.00K

882.22%442.00K

--528.00K

--640.00K

--832.00K

--45.00K

主營業務成本

--200.00K

--1.08M

----

營業費用

35.20%151.11M

47.58%139.83M

62.57%142.73M

56.46%130.14M

50.69%111.77M

51.21%94.75M

48.00%87.80M

54.09%83.18M

46.41%74.17M

29.82%62.66M

35.10%59.32M

24.14%53.98M

37.07%50.66M

50.99%48.27M

57.92%43.91M

66.68%43.48M

61.26%36.96M

46.69%31.97M

50.71%27.81M

54.11%26.09M

28.37%22.92M

40.27%21.79M

17.27%18.45M

26.86%16.93M

71.48%17.85M

52.12%15.54M

82.57%15.73M

110.49%13.35M

74.45%10.41M

237.14%10.21M

185.93%8.62M

156.16%6.34M

124.87%5.97M

--3.03M

--3.01M

--2.48M

--2.65M

研發費用

31.27%100.08M

27.77%85.05M

46.13%90.46M

37.63%80.30M

42.93%76.24M

46.04%66.57M

41.21%61.91M

43.56%58.34M

38.66%53.34M

23.22%45.58M

37.05%43.84M

23.17%40.64M

36.16%38.47M

50.35%36.99M

48.23%31.99M

61.05%32.99M

60.67%28.25M

46.19%24.60M

57.53%21.58M

62.50%20.49M

26.85%17.58M

38.60%16.83M

15.87%13.70M

22.58%12.61M

91.07%13.86M

58.71%12.14M

71.70%11.82M

96.96%10.29M

53.71%7.25M

198.63%7.65M

172.93%6.89M

150.70%5.22M

128.57%4.72M

--2.56M

--2.52M

--2.08M

--2.06M

折舊攤銷及損耗

25.41%1.16M

26.14%994.00K

31.43%1.01M

27.36%959.00K

95.15%925.00K

200.76%788.00K

182.05%770.00K

168.93%753.00K

67.49%474.00K

-6.43%262.00K

10.08%273.00K

30.23%280.00K

17.92%283.00K

19.15%280.00K

6.44%248.00K

-6.52%215.00K

7.14%240.00K

4.44%235.00K

-4.51%233.00K

-5.74%230.00K

-4.68%224.00K

-1.75%225.00K

7.02%244.00K

6.09%244.00K

17.50%235.00K

10.10%229.00K

64.03%228.00K

202.63%230.00K

316.67%200.00K

333.33%208.00K

189.58%139.00K

204.00%76.00K

77.78%48.00K

--48.00K

--25.00K

--27.00K

營業利潤

-26.01%-140.38M

-41.08%-133.67M

-62.40%-142.59M

-55.96%-129.11M

-51.51%-111.41M

-51.21%-94.75M

-48.87%-87.80M

-56.21%-82.78M

-53.26%-73.53M

-31.76%-62.66M

-35.72%-58.98M

-23.12%-52.99M

-41.83%-47.98M

-53.96%-47.56M

-56.27%-43.45M

-64.99%-43.05M

-47.60%-33.83M

-41.75%-30.89M

-50.71%-27.81M

-54.11%-26.09M

-28.88%-22.92M

-43.23%-21.79M

-21.16%-18.45M

-26.86%-16.93M

-77.04%-17.78M

-61.32%-15.21M

-88.71%-15.23M

-134.82%-13.35M

-81.76%-10.04M

-277.09%-9.43M

-239.93%-8.07M

-245.89%-5.68M

-111.81%-5.53M

---2.50M

---2.37M

---1.64M

---2.61M

淨非營業利息收入（費用）

利息收入

-14.63%12.66M

-22.36%11.16M

13.97%12.54M

53.93%13.46M

102.65%14.83M

113.75%14.37M

328.42%11.01M

314.86%8.74M

259.18%7.32M

253.05%6.72M

71.27%2.57M

192.64%2.11M

955.96%2.04M

2280.00%1.90M

6150.00%1.50M

3030.43%720.00K

543.33%193.00K

50.94%80.00K

-80.33%24.00K

-91.15%23.00K

-94.60%30.00K

-91.91%53.00K

-85.39%122.00K

-72.92%260.00K

-44.95%556.00K

-34.43%655.00K

56.37%835.00K

535.76%960.00K

1478.13%1.01M

16550.00%999.00K

8800.00%534.00K

2057.14%151.00K

814.29%64.00K

--6.00K

--7.00K

利息費用

----

-100.00%0.00

--1.00K

--2.00K

--3.00K

--2.00K

出售證券收益

----

178.05%32.00K

100.57%34.00K

-238.18%-186.00K

-17.79%23.10M

-10.81%-41.00K

-7400.00%-6.00M

-423.53%-55.00K

401528.57%28.10M

21.28%-37.00K

-175.86%-80.00K

170.83%17.00K

---7.00K

---47.00K

---29.00K

---24.00K

----

特殊收入（費用）

----

--0.00

----

-100.00%0.00

--0.00

-100.00%0.00

----

--569.00K

--0.00

--31.00K

----

其他非經營性收入（費用）

35.47%-131.00K

42.66%-125.00K

28.99%-49.00K

142.55%20.00K

-212.31%-203.00K

99.05%-218.00K

-475.00%-69.00K

-100.80%-47.00K

---65.00K

17.66%-23.06M

-118.18%-12.00K

591000.00%5.91M

----

-133471.43%-28.01M

414.29%66.00K

---1.00K

----

-78.35%21.00K

-333.33%-21.00K

----

108.21%11.00K

870.00%97.00K

125.00%9.00K

523.81%178.00K

-844.44%-134.00K

115.87%10.00K

30.77%-36.00K

-16.67%-42.00K

1000.00%18.00K

-152.00%-63.00K

-333.33%-52.00K

-300.00%-36.00K

0.00%-2.00K

---25.00K

---12.00K

---9.00K

---2.00K

稅前利潤

-32.11%-127.84M

-52.16%-122.64M

-69.33%-130.09M

-56.15%-115.64M

-45.61%-96.77M

-44.19%-80.59M

-36.07%-76.83M

-45.27%-74.06M

-44.49%-66.46M

-24.24%-55.90M

-34.67%-56.46M

-20.30%-50.98M

-36.82%-45.99M

-46.10%-44.99M

-50.53%-41.92M

-62.39%-42.38M

-46.79%-33.62M

-42.29%-30.79M

-52.03%-27.85M

-58.24%-26.09M

-31.92%-22.90M

-48.75%-21.64M

-26.96%-18.32M

-32.70%-16.49M

-92.55%-17.36M

-71.27%-14.55M

-90.17%-14.43M

-123.19%-12.43M

-65.01%-9.02M

-236.97%-8.49M

-218.56%-7.59M

-237.86%-5.57M

-109.67%-5.46M

---2.52M

---2.38M

---1.65M

---2.61M

所得稅

----

--180.00K

----

--0.00

----

--0.00

----

除稅後的權益收益

----

--0.00

----

100.00%0.00

--0.00

---470.00K

---4.20M

---997.00K

--0.00

100.00%0.00

--0.00

---1.01M

----

除稅後利潤

-32.11%-127.84M

-52.39%-122.81M

-69.33%-130.09M

-56.15%-115.64M

-45.61%-96.77M

-44.19%-80.59M

-36.07%-76.83M

-45.27%-74.06M

-44.49%-66.46M

-24.24%-55.90M

-34.67%-56.46M

-20.30%-50.98M

-36.82%-45.99M

-46.10%-44.99M

-50.53%-41.92M

-62.39%-42.38M

-46.79%-33.62M

-42.29%-30.79M

-52.03%-27.85M

-58.24%-26.09M

-31.92%-22.90M

-48.75%-21.64M

-26.96%-18.32M

-32.70%-16.49M

-92.55%-17.36M

-71.27%-14.55M

-90.17%-14.43M

-123.19%-12.43M

-65.01%-9.02M

-236.97%-8.49M

-218.56%-7.59M

-237.86%-5.57M

-109.67%-5.46M

---2.52M

---2.38M

---1.65M

---2.61M

持續經營利潤

-32.11%-127.84M

-52.39%-122.81M

-69.33%-130.09M

-56.15%-115.64M

-44.59%-96.77M

-34.11%-80.59M

-33.71%-76.83M

-45.27%-74.06M

-45.52%-66.93M

-33.58%-60.10M

-37.05%-57.46M

-20.30%-50.98M

-32.83%-45.99M

-46.10%-44.99M

-50.53%-41.92M

-62.39%-42.38M

-51.20%-34.63M

-42.29%-30.79M

-52.03%-27.85M

-58.24%-26.09M

-31.92%-22.90M

-48.75%-21.64M

-26.96%-18.32M

-32.70%-16.49M

-92.55%-17.36M

-71.27%-14.55M

-90.17%-14.43M

-123.19%-12.43M

-65.01%-9.02M

-236.97%-8.49M

-218.56%-7.59M

-237.86%-5.57M

-109.67%-5.46M

---2.52M

---2.38M

---1.65M

---2.61M

反常淨利潤

----

--0.00

----

歸属于母公司的淨利潤

-32.11%-127.84M

-52.39%-122.81M

-69.33%-130.09M

-56.15%-115.64M

-44.59%-96.77M

-34.11%-80.59M

-33.71%-76.83M

-45.27%-74.06M

-45.52%-66.93M

-33.58%-60.10M

-37.05%-57.46M

-20.30%-50.98M

-32.83%-45.99M

-46.10%-44.99M

-50.53%-41.92M

-62.39%-42.38M

-51.20%-34.63M

-42.29%-30.79M

-52.03%-27.85M

-58.24%-26.09M

-31.92%-22.90M

-48.75%-21.64M

-26.96%-18.32M

-32.70%-16.49M

-92.55%-17.36M

-71.27%-14.55M

-90.17%-14.43M

-123.19%-12.43M

-65.01%-9.02M

-236.97%-8.49M

-218.56%-7.59M

-237.86%-5.57M

-109.67%-5.46M

---2.52M

---2.38M

---1.65M

---2.61M

歸屬普通股東的淨利潤

-32.11%-127.84M

-52.39%-122.81M

-69.33%-130.09M

-56.15%-115.64M

-44.59%-96.77M

-34.11%-80.59M

-33.71%-76.83M

-45.27%-74.06M

-45.52%-66.93M

-33.58%-60.10M

-37.05%-57.46M

-20.30%-50.98M

-32.83%-45.99M

-46.10%-44.99M

-50.53%-41.92M

-62.39%-42.38M

-51.20%-34.63M

-42.29%-30.79M

-52.03%-27.85M

-58.24%-26.09M

-31.92%-22.90M

-48.75%-21.64M

-26.96%-18.32M

-32.70%-16.49M

-92.55%-17.36M

-71.27%-14.55M

-90.17%-14.43M

-123.19%-12.43M

-65.01%-9.02M

-236.97%-8.49M

-218.56%-7.59M

-237.86%-5.57M

-109.67%-5.46M

---2.52M

---2.38M

---1.65M

---2.61M

基本每股收益

-18.15%-1.23

-46.79%-1.29

-43.94%-1.38

-31.54%-1.23

-12.27%-1.04

1.52%-0.88

5.16%-0.96

0.21%-0.94

-8.52%-0.93

-6.94%-0.89

-29.72%-1.01

-16.42%-0.94

-17.56%-0.85

-22.89%-0.84

-7.25%-0.78

-14.58%-0.81

-4.62%-0.73

-3.55%-0.68

-30.52%-0.73

-34.11%-0.70

2.14%-0.69

-9.34%-0.66

6.55%-0.56

-2.08%-0.53

-89.45%-0.71

-74.17%-0.60

-88.81%-0.60

-121.92%-0.51

-50.72%-0.37

-200.91%-0.34

-191.70%-0.32

-209.52%-0.23

-109.67%-0.25

---0.11

---0.07

---0.12

稀釋每股收益

-18.15%-1.23

-46.79%-1.29

-43.94%-1.38

-31.54%-1.23

-12.27%-1.04

1.52%-0.88

5.16%-0.96

0.21%-0.94

-8.52%-0.93

-6.94%-0.89

-29.72%-1.01

-16.42%-0.94

-17.56%-0.85

-22.89%-0.84

-7.25%-0.78

-14.58%-0.81

-4.62%-0.73

-3.55%-0.68

-30.52%-0.73

-34.11%-0.70

2.14%-0.69

-9.34%-0.66

6.55%-0.56

-2.08%-0.53

-89.45%-0.71

-74.17%-0.60

-88.81%-0.60

-121.92%-0.51

-50.72%-0.37

-200.91%-0.34

-191.70%-0.32

-209.52%-0.23

-109.67%-0.25

---0.11

---0.07

---0.12

每股派息

--0.00

-100.00%0.00

--0.00

--0.42

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Crinetics Pharmaceuticals Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 CRNX 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Crinetics Pharmaceuticals Inc 財年末的營收是多少？



Crinetics Pharmaceuticals Inc 2025 財年營收為 7.70M，高於上一財年的 1.04M。

Crinetics Pharmaceuticals Inc 最近一個季度的營收是多少？



Crinetics Pharmaceuticals Inc 最近一個季度的營收為 10.73M，同比增長 2873.41%。

Crinetics Pharmaceuticals Inc 全年的淨利潤是多少？



Crinetics Pharmaceuticals Inc 2025 財年淨利潤為 -465.32M。

Crinetics Pharmaceuticals Inc 上一季度的淨利潤是多少？



Crinetics Pharmaceuticals Inc 最近一個季度的淨利潤為 -127.84M。

Crinetics Pharmaceuticals Inc 年度營業利潤是多少？



Crinetics Pharmaceuticals Inc 2025 財年的營業利潤為 -516.77M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。